BOTOX, NERVE STIMULATION DEVICES, MIRABEGRON, AND ANTICHOLINERGICS VERSUS BEST SUPPORTIVE CARE FOR OVERACTIVE BLADDER: AN UPDATED US COST-EFFECTIVENESS ANALYSIS Meeting Abstract

publication date

  • February 1, 2021

webpage

published in

start page

  • S157

end page

  • S157

volume

  • 40